"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT05075811","Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease",,"Recruiting","No Results Available","Pouch, Ileal|Fistula","Drug: Ossium vBM-MSC|Other: Placebo","Treatment related adverse events|Complete clinical healing|Partial healing|Lack of response|Worsening disease","Amy Lightner|Ossium Health, Inc.|The Cleveland Clinic","All","18 Years to 75 Years Â  (Adult, Older Adult)","Phase 1|Phase 2","20","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","21-860","February 1, 2022","November 15, 2024","November 15, 2024","October 13, 2021",,"April 5, 2022","Cleveland Clinic, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT05075811"
